Literature DB >> 22564408

The effect of induced anti-follicle-stimulating hormone autoantibody on serum hormone level and apoptosis in rat testis.

Bing Yao1, Nan Yi, Shuigen Zhou, Weiming OuYang, Huiru Xu, Yifeng Ge, Yingxia Cui, Xinyi Xia.   

Abstract

AIMS: Anti-follicle-stimulating hormone (FSH) autoantibody was found to highly correlate with oligospermia and asthenospermia, but the actual effect of FSH autoantibody on spermatogenesis is still unknown. MAIN
METHODS: In this study, 21-day rats were immunized seven times with FSH peptides linked with Keyhole Limpet Hemocyanin (KLH) (experimental group) or KLH (control group) every 2 weeks. Luteinizing hormone (LH) and inhibin B level in the immunized rat sera were measured by enzyme-linked immunosorbent assay (ELISA). Apoptosis of spermatogenic cells in the testis was detected by in situ end labeling method (TUNEL), and the mRNAs of Bax, Bcl-2 and Caspase-3 in testis were detected by fluorescent Quantitative PCR. KEY
FINDINGS: Compared with the control, serum inhibin B level was significantly decreased at all time points (34.49%, 23.20%, and 37.00%) (p<0.05). There was no difference in the serum LH level between experimental and control groups. FSH peptide immunization increased the apoptosis of spermatogenic cells in the testis that was associated with an imbalance of Bax and Bcl-2 expression and upregulation of Caspase-3. SIGNIFICANCE: These results suggest that FSH autoantibody could cause the reduction of inhibin B, thereby inducing hypospermatogenesis via augment of spermatogenic cell apoptosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564408     DOI: 10.1016/j.lfs.2012.04.026

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Phosphoribosyl-pyrophosphate synthetase 2 (PRPS2) depletion regulates spermatogenic cell apoptosis and is correlated with hypospermatogenesis.

Authors:  Bin Lei; Li-Xia Xie; Shou-Bo Zhang; Bo Wan; Li-Ren Zhong; Xu-Ming Zhou; Xiang-Ming Mao; Fang-Peng Shu
Journal:  Asian J Androl       Date:  2020 Sep-Oct       Impact factor: 3.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.